Photonic Viropsy: Harnessing light on chip for precise SARS-CoV-2 diagnosis

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA149258

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $426,193.52
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Principal Investigator

    N/A

  • Research Location

    Australia
  • Lead Research Institution

    THE UNIVERSITY OF ADELAIDE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Progress in nanotechnology is driving the development of analytical tools capable of unlocking the powerful information encoded in biological fluids. Harnessing such precious information will be critical to enabling breakthroughs in the understanding and control of present and future pandemics. The project will tailor and validate a mature yet cutting-edge sensing technology specifically for integrated, precise diagnosis of SARS-CoV-2. This will allow deep insights into how concentrations of serological markers of this virus in symptomatic and asymptomatic patients are associated with the uncontrolled spread of this deadly disease & with significant benefits for addressing current and future pandemic threats to our society and economy.